Login
Contact us
0
Search
Toggle navigation
About
About Hodoodo
Contact Hodoodo
About Hodoodo Products
Careers at Hodoodo
Licensing
Remove your patented product from our web
Products
Browse all products
Browse products by research area
Newest stocked products
Featured products
Services
Custom Synthesis
Frequently asked questions
Process Research & Development
Ordering
How To Order
Terms and Conditions
Request Quote
Privacy Policy
Resources
News
Elemental Period Table
Download Hodoodo Catalogues
Amino Acid Nomenclature Guide
Useful Free Databases
NMR Chemical Shifts of Impurities Charts
Drug Synthesis
Structure search
Newest Products
E7820
CAT#: H201090
CAS#: 289483-69-8
E7820 is a α2 integrin inhibitor with potential antiangiogenic and antitumor activities. E7820 inhibits angiogenesis by suppressing integrin alpha 2, …
Stenoparib
CAT#: H205882
CAS#: 1140964-99-3
Stenoparib, also known as E7449 and 2X-121, is an orally available small molecule inhibitor of the nuclear enzymes poly (ADP-ribose) polymerase (PARP…
Daniquidone
CAT#: H205960
CAS#: 67199-66-0
Daniquidone, also known as Batracylin, is a water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomer…
Dacinostat free base
CAT#: H200845
CAS#: 404951-53-7 (free base)
Dacinostat, also known as LAQ824, is a hydroxamate histone deacetylase inhibitor with potential anticancer activity. LAQ824 sensitized nonsmall cell l…
CYC116
CAT#: H200844
CAS#: 693228-63-6
CYC116 is an orally bioavailable small molecule multi-kinase inhibitor with antineoplastic activity. Aurora kinase/VEGFR 2 inhibitor CYC116 inhibits A…
CP-609754
CAT#: H206096
CAS#: 1190094-64-4
CP-609754, also known as CP-609,754, LNK 754 and OSI 754, is a potent farnesyltransferase inhibitor with potential anticancer activity.
Namodenoson
CAT#: H206154
CAS#: 163042-96-4
Namodenoson, also known as 2-Cl-IB-MECA and CF-102, is an orally bioavailable, synthetic, highly selective adenosine A3 receptor (A3AR) agonist with …
Delanzomib (CEP-18770)
CAT#: H200713
CAS#: 847499-27-8
Delanzomib, also known as CEP-18770, is An orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin-like activity of the …
CC-115
CAT#: H205829
CAS#: 1228013-15-7 (free base)
CC-115 is a dual inhibitor of DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR), with potential antineoplastic activity. …
BNC-105
CAT#: H204760
CAS#: 945771-74-4
BNC105 is a novel compound being developed by Bionomics as a Vascular Disrupting Agent (VDA) for treatment of cancer. VDAs are drugs that disrupt the …
Barasertib
CAT#: H200420
CAS#: 722543-31-9 (free acid)
Barasertib is an orally bioavailable, small-molecule, dihydrogen phosphate prodrug of the pyrazoloquinazoline Aurora kinase inhibitor AZD1152–hydroxyq…
Derazantinib
CAT#: H205946
CAS#: 1234356-69-4
Derazantinib, also known as ARQ-087, is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic…
Aroplatin
CAT#: H200280
CAS#: 114488-24-3
Aroplatin is a synthetic liposomal formulation of bis-neodecanoate diaminocyclohexane platinum (NDDP), a third-generation platinum complex analogue of…
Rimiducid
CAT#: H205899
CAS#: 195514-63-7
Rimiducid, also known as AP1903, is a lipid-permeable bivalent "dimerizer" drug that binds FKBP and induces Fas cross-linking. AP1903 induced iCasp9 a…
Anaxirone
CAT#: H206057
CAS#: 77658-97-0
Anaxirone is a synthetic triepoxide alkylating agent with potential antineoplastic activity. Anaxirone alkylates DNA via actual or derived epoxide gro…
Anlotinib HCl
CAT#: H206058
CAS#: 1360460-82-7 (HCl)
Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic act…
Altiratinib
CAT#: H206143
CAS#: 1345847-93-9
Altiratinib, also known as DCC-270, DP-5164, is an oral, selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases with potential ant…
AG-490
CAT#: H200121
CAS#: 133550-30-8
Tyrphostin AG490 is a JAK-2 specific inhibitor, which inhibits phosphorylation of EGFR and signal transducer and activator of transcription 3 [STAT-3]…
AC430
CAT#: H205897
CAS#: 1361415-84-0 (free base)
AC430 is a potent and specific small molecule inhibitor of janus kinase 2 (JAK2), which has been implicated as a target for therapy in both oncology a…
ABT-737
CAT#: H200444
CAS#: 852808-04-9
ABT-737 is an orally available inhibitor of the nuclear enzymes poly(ADP-ribose) polymerase (PARP) 1 and 2, with potential antineoplastic activity. Up…
4SC-203
CAT#: H205802
CAS#: 895533-09-2
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. Multikinase inhibitor 4SC-203 selectively inhibits FMS-related tyrosine kin…
Radotinib
CAT#: H205990
CAS#: 926037-48-1 (free base)
Radotinib, also known as IY-5511, is an orally available, a second-generation tyrosine kinase inhibitor of Bcr-Abl fusion protein and the platelet-der…
Raltitrexed
CAT#: H100762
CAS#: 112887-68-0
Raltitrexed, also known as ZD 1694, is an antimetabolite drug used in treatment of colorectal cancer since 1998. It may also be used in the treatment…
Pirarubicin
CAT#: H100734
CAS#: 72496-41-4 (free base)
Pirarubicin is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and in…
Maropitant free base
CAT#: H120201
CAS#: 147116-67-4 (free base)
Maropitan, also known as CJ 11972, is a neurokinin (NK1) receptor antagonist, which was developed by Zoetis specifically for the treatment of motion s…
« First
‹ Prev
1
...
72
73
74
75
76
Next ›
Last »